Epoetin Alfa Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Reference Brands: EPOGEN (USA), PROCRIT (USA)
Category: Anemia
Epoetin alfa is a recombinant human erythropoietin that stimulates red blood cell production in the bone marrow. It is primarily used to treat anemia caused by chronic kidney disease, chemotherapy, or certain HIV treatments. Administered by injection, it helps reduce the need for blood transfusions in patients with low hemoglobin levels. Marketed under brand names such as Epogen, Procrit, and Eprex, this biologic drug has become a key therapy for managing anemia due to insufficient erythropoietin production. Epoetin alfa is available in injection (prefilled syringe) and strengths such as 1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Epoetin alfa is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Epoetin alfa can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Epoetin alfa is used to treat anemia caused by chronic kidney disease, chemotherapy, or certain treatments for HIV. It helps increase red blood cell production in the bone marrow, reducing the need for blood transfusions and improving energy levels and overall quality of life for patients with low hemoglobin levels.
Epoetin alfa is made from recombinant human erythropoietin, a protein produced using recombinant DNA technology that stimulates red blood cell production.
The common trade names of Epoetin alfa include Epogen, Procrit, and Eprex.
Epoetin alfa (Epogen and Procrit) is manufactured by Amgen and Johnson & Johnson, and Eprex is produced by Janssen-Cilag in Europe.
The generic name of Epoetin alfa is Epoetin alfa.
The brand names of Epoetin alfa are Epogen, Procrit, and Eprex.
Epoetin alfa is manufactured in the United States, Europe, and other countries by approved pharmaceutical companies under GMP-certified conditions.
Related Products
Ferumoxytol Injection
Strength:
30 mg/mL
Form: Injection
Reference Brands: Feraheme (USA)
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Deferasirox
Strength:
125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View Details
Iron(Iii)-Isomaltoside Injection
Strength:
100mg/ml
Form: Injection
Reference Brands: Monofer,, Diafer, Monoferric
View DetailsQuick Response Guaranteed | Verified Suppliers
